Assessment of Pharmacological Responses to an Anti-diabetic Drug in a New Obese Type 2 Diabetic Rat Model.

about

Assessment of Pharmacological Responses to an Anti-diabetic Drug in a New Obese Type 2 Diabetic Rat Model.

Item

http://www.wikidata.org/entity/Q50129534

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Assessment of Pharmacological ...... ese Type 2 Diabetic Rat Model.

@en

Assessment of Pharmacological ...... ese Type 2 Diabetic Rat Model.

@nl

type

Item

label

Assessment of Pharmacological ...... ese Type 2 Diabetic Rat Model.

@en

Assessment of Pharmacological ...... ese Type 2 Diabetic Rat Model.

@nl

prefLabel

Assessment of Pharmacological ...... ese Type 2 Diabetic Rat Model.

@en

Assessment of Pharmacological ...... ese Type 2 Diabetic Rat Model.

@nl

P1476

Assessment of Pharmacological ...... bese Type 2 Diabetic Rat Model

@en

P2093

Fatchiyah Fatchiyah

http://www.w3.org/2001/XMLSchema#string

Hironobu Tadaki

http://www.w3.org/2001/XMLSchema#string

Katsuhiro Miyajima

http://www.w3.org/2001/XMLSchema#string

Masami Shinohara

http://www.w3.org/2001/XMLSchema#string

Takahisa Yamada

http://www.w3.org/2001/XMLSchema#string

Yasutaka Murai

http://www.w3.org/2001/XMLSchema#string

P2860

Mechanism by which metformin reduces glucose production in type 2 diabetes

Role of KLF15 in regulation of hepatic gluconeogenesis and metformin action

Current understanding of metformin effect on the control of hyperglycemia in diabetes

Effect of BRX-220 against peripheral neuropathy and insulin resistance in diabetic rat models

Epidemic obesity and type 2 diabetes in Asia

Mechanism of fat-induced hepatic gluconeogenesis: effect of metformin

Obesity-associated hypertension and kidney disease.

Metabolic effects of metformin in non-insulin-dependent diabetes mellitus.

Treating dual defects in diabetes: insulin resistance and insulin secretion.

Contribution of hyperglycemia on diabetic complications in obese type 2 diabetic SDT fatty rats: effects of SGLT inhibitor phlorizin

P304

380-384

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5455/MEDARH.2017.71.380-384

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Takeshi Ohta

P577

2017-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29416195

http://www.w3.org/2001/XMLSchema#string

P921

Adipositas

P932

5764610

http://www.w3.org/2001/XMLSchema#string